According to the research report, the global medicalplastic compounds market size is expected to touch USD 79.56 Billion by 2027, from USD 52.24 Billion in 2019, growing with a significant CAGR of 5.4% from2020 to 2027.
The medical plastic compounds market report
offers a comprehensive study of the current state expected at the major
drivers, market strategies, and key vendors’ growth. The report presents
energetic visions to conclude and study the market size, market hopes, and
competitive surroundings. The research also focuses on the important
achievements of the market, research & development, and regional growth of
the leading competitors operating in the market. The current trends of the
global medical plastic compounds market in conjunction with the geographical
landscape of this vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global medical plastic compounds market, which aids
companies operating in the market in making strategic development decisions.
The study also elaborates on significant changes that are highly anticipated to
configure growth of the global medical plastic compounds market during the
forecast period. It also includes a key indicator assessment that highlights
growth prospects of this market and estimates statistics related to growth of
the market in terms of value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/1155
Report Highlights | Details |
Market Size | USD 79.56 Billion by 2027 |
Growth Rate | CAGR of 5.4% from 2021 to 2027 |
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2021 |
Forecast Period | 2021 to 2027 |
Segments Covered | Product, Application, Region |
This study covers a detailed segmentation
of the global medical plastic compounds market, along with key information and
a competition outlook. The report mentions company profiles of players that are
currently dominating the global medical plastic compounds market, wherein
various developments, expansions, and winning strategies practiced and
implemented by leading players have been presented in detail.
Key Players
- Nolato AB
- Freudenberg Medical LLC
- Rochling Group
- GW Plastics Inc.
- MedPlast Inc.
- Phillips Medisisze Corporation
- C&J Industries Inc.
- Tekni-Plex, Inc.
- Pexco LLC
- Medical Plastic Devices Inc.
Market Segmentation
- Polyethylene
- Polyvinylchloride
- Polypropylene
- Polyester
- Polystyrene
- Polycarbonate
- Acrylics
- Polyurethane
- Others
By Application
- Catheters
- Disposables
- Drug Delivery System
- Surgical Instruments
- Implants
- Medical Bags
- Others
By Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Research Methodology
The research methodology adopted by
analysts for compiling the global medical plastic compounds market report is
based on detailed primary as well as secondary research. With the help of
in-depth insights of the market-affiliated information that is obtained and
legitimated by market-admissible resources, analysts have offered riveting
observations and authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary
understanding of the global medical plastic compounds market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Medical Plastic Compounds Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Plastic Compounds Market
5.1. Covid-19: Medical Plastic Compounds Industry Impact
5.2. Medical Plastic Compounds Business Impact Assessment: Covid-19
5.2.1. Supply Chain Challenges/Disruption
5.2.2. Market Trends and Medical Plastic Compounds Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Medical Plastic Compounds Manufacturers to deal with Covid-19 Pandemic Scenario
Chapter 6. Medical Plastic Compounds Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing Prevalence of Chronic Disease
6.1.1.2. Rising Consumption of Polymers in Healthcare Industry
6.1.2. Market Restraints
6.1.2.1. Volatile Prices of Raw Materials
6.1.3. Market Opportunities
6.1.3.1. Increasing Research Activities to Develop Advanced Medical Grade Plastics
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Global Medical Plastic Compounds Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Medical Plastic Compounds Market Revenue by Manufacturer (2015-2020)
7.1.1.2. Medical Plastic Compounds Market Revenue Market Share by Manufacturer (2015-2020)
7.1.1.3. Medical Plastic Compounds Market Production by Manufacturer (2015-2020)
7.1.1.4. Medical Plastic Compounds Market Production Market Share by Manufacturer (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Capacity Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Manufacturers Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Plastic Compounds Market, By Product
8.1. Medical Plastic Compounds Market, by Product, 2016-2027
8.1.1. Polyethylene
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.1.2. Market Production and Forecast (2016-2027)
8.1.2. Polyvinylchloride
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.2.2. Market Production and Forecast (2016-2027)
8.1.3. Polypropylene
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.3.2. Market Production and Forecast (2016-2027)
8.1.4. Polyester
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.4.2. Market Production and Forecast (2016-2027)
8.1.5. Polystyrene
8.1.5.1. Market Revenue and Forecast (2016-2027)
8.1.5.2. Market Production and Forecast (2016-2027)
8.1.6. Polycarbonate
8.1.6.1. Market Revenue and Forecast (2016-2027)
8.1.6.2. Market Production and Forecast (2016-2027)
8.1.7. Acrylics
8.1.7.1. Market Revenue and Forecast (2016-2027)
8.1.7.2. Market Production and Forecast (2016-2027)
8.1.8. Polyurethane
8.1.8.1. Market Revenue and Forecast (2016-2027)
8.1.8.2. Market Production and Forecast (2016-2027)
8.1.9. Others
8.1.9.1. Market Revenue and Forecast (2016-2027)
8.1.9.2. Market Production and Forecast (2016-2027)
Chapter 9. Global Medical Plastic Compounds Market, By Application
9.1. Medical Plastic Compounds Market, by Application, 2016-2027
9.1.1. Catheters
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.1.2. Market Consumption and Forecast (2016-2027)
9.1.2. Disposables
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.2.2. Market Consumption and Forecast (2016-2027)
9.1.3. Drug Delivery System
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.3.2. Market Consumption and Forecast (2016-2027)
9.1.4. Surgical Instruments
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.4.2. Market Consumption and Forecast (2016-2027)
9.1.5. Implants
9.1.5.1. Market Revenue and Forecast (2016-2027)
9.1.5.2. Market Consumption and Forecast (2016-2027)
9.1.6. Medical Bags
9.1.6.1. Market Revenue and Forecast (2016-2027)
9.1.6.2. Market Consumption and Forecast (2016-2027)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2016-2027)
9.1.7.2. Market Consumption and Forecast (2016-2027)
Chapter 10. Global Medical Plastic Compounds Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Production Forecast by Product (2016-2027)
10.1.2. Market Revenue and Consumption Forecast by Application (2016-2027)
10.1.3. U.S
10.1.3.1. Market Revenue and Production Forecast (2016-2027)
10.1.3.2. Market Revenue and Consumption Forecast (2016-2027)
10.1.4. Canada
10.1.4.1. Market Revenue and Production Forecast (2016-2027)
10.1.4.2. Market Revenue and Consumption Forecast (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Production Forecast by Product (2016-2027)
10.2.2. Market Revenue and Consumption Forecast by Application (2016-2027)
10.2.3. UK
10.2.3.1. Market Revenue and Production Forecast (2016-2027)
10.2.3.2. Market Revenue and Consumption Forecast (2016-2027)
10.2.4. Germany
10.2.4.1. Market Revenue and Production Forecast (2016-2027)
10.2.4.2. Market Revenue and Consumption Forecast (2016-2027)
10.2.5. France
10.2.5.1. Market Revenue and Production Forecast (2016-2027)
10.2.5.2. Market Revenue and Consumption Forecast (2016-2027)
10.2.6. Rest of EU
10.2.6.1. Market Revenue and Production Forecast (2016-2027)
10.2.6.2. Market Revenue and Consumption Forecast (2016-2027)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue and Production Forecast by Product (2016-2027)
10.3.2. Market Revenue and Consumption Forecast by Application (2016-2027)
10.3.3. China
10.3.3.1. Market Revenue and Production Forecast (2016-2027)
10.3.3.2. Market Revenue and Consumption Forecast (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Production Forecast (2016-2027)
10.3.4.2. Market Revenue and Consumption Forecast (2016-2027)
10.3.5. Japan
10.3.5.1. Market Revenue and Production Forecast (2016-2027)
10.3.5.2. Market Revenue and Consumption Forecast (2016-2027)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Production Forecast (2016-2027)
10.3.6.2. Market Revenue and Consumption Forecast (2016-2027)
10.4. LATAM
10.4.1. Market Revenue and Production Forecast by Product (2016-2027)
10.4.2. Market Revenue and Consumption Forecast by Application (2016-2027)
10.4.3. Brazil
10.4.3.1. Market Revenue and Production Forecast (2016-2027)
10.4.3.2. Market Revenue and Consumption Forecast (2016-2027)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue and Production Forecast (2016-2027)
10.4.4.2. Market Revenue and Consumption Forecast (2016-2027)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue and Production Forecast by Product (2016-2027)
10.5.2. Market Revenue and Consumption Forecast by Application (2016-2027)
10.5.3. GCC
10.5.3.1. Market Revenue and Production Forecast (2016-2027)
10.5.3.2. Market Revenue and Consumption Forecast (2016-2027)
10.5.4. North Africa
10.5.4.1. Market Revenue and Production Forecast (2016-2027)
10.5.4.2. Market Revenue and Consumption Forecast (2016-2027)
10.5.5. South Africa
10.5.5.1. Market Revenue and Production Forecast (2016-2027)
10.5.5.2. Market Revenue and Consumption Forecast (2016-2027)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue and Production Forecast (2016-2027)
10.5.6.2. Market Revenue and Consumption Forecast (2016-2027)
Chapter 11. Company Profiles
11.1. Nolato AB
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.1.4. Recent Developments and Strategies
11.2. Freudenberg Medical LLC
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.2.4. Recent Developments and Strategies
11.3. Rochling Group
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.3.4. Recent Developments and Strategies
11.4. GW Plastics Inc.
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.4.4. Recent Developments and Strategies
11.5. MedPlast Inc.
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.5.4. Recent Developments and Strategies
11.6. Phillips Medisisze Corporation
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.6.4. Recent Developments and Strategies
11.7. C&J Industries Inc.
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.7.4. Recent Developments and Strategies
11.8. Tekni-Plex, Inc.
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.8.4. Recent Developments and Strategies
11.9. Pexco LLC
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.9.4. Recent Developments and Strategies
11.10. Medical Plastic Devices Inc.
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.10.4. Recent Developments and Strategies
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments